Lactose Intolerance – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Lactose intolerance is an impaired ability to digest lactose, a sugar found in milk and other dairy products. Mutations in the LCT gene cause lactose intolerance in infants (congenital lactase deficiency). The LCT gene provides instructions for making the lactase enzyme. A DNA sequence controls LCT gene expression called a regulatory element located within a nearby gene called MCM6. · In the Americas, the lactose intolerance prevalence estimates ranged from 36% in the USA to 80% in Colombia Thelansis’s “Lactose Intolerance Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Lactose Intolerance treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK,